Nissan Medical Industries Ltd (TLV:NISA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,069.00
0.00 (0.00%)
Apr 2, 2025, 5:24 PM IDT

Nissan Medical Industries Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
971169878199260
Upgrade
Market Cap Growth
18.15%18.15%25.68%-60.78%-23.34%112.17%
Upgrade
Enterprise Value
407413431433525594
Upgrade
Last Close Price
10.6912.7610.258.1620.4025.73
Upgrade
PE Ratio
12.2914.6617.37-5.534.57
Upgrade
PS Ratio
0.150.180.130.110.300.36
Upgrade
PB Ratio
0.400.330.280.240.580.80
Upgrade
P/TBV Ratio
0.600.600.510.441.181.73
Upgrade
P/FCF Ratio
4.685.591.0231.3020.272.39
Upgrade
P/OCF Ratio
4.324.320.936.6911.072.12
Upgrade
EV/Sales Ratio
0.610.620.590.630.790.82
Upgrade
EV/EBITDA Ratio
6.716.964.9619.445.754.31
Upgrade
EV/EBIT Ratio
13.1313.927.02-7.985.38
Upgrade
EV/FCF Ratio
19.6119.914.49173.4453.485.47
Upgrade
Debt / Equity Ratio
0.570.570.560.760.700.74
Upgrade
Debt / EBITDA Ratio
3.413.412.149.342.631.75
Upgrade
Debt / FCF Ratio
9.769.762.07100.6724.532.21
Upgrade
Asset Turnover
0.940.941.020.930.931.04
Upgrade
Inventory Turnover
3.983.985.405.666.448.64
Upgrade
Quick Ratio
0.390.390.620.660.740.71
Upgrade
Current Ratio
1.111.111.161.171.341.00
Upgrade
Return on Equity (ROE)
3.89%3.89%5.54%-13.99%17.11%31.05%
Upgrade
Return on Assets (ROA)
2.62%2.62%5.32%-0.15%5.75%9.92%
Upgrade
Return on Capital (ROIC)
3.34%3.34%6.75%-0.19%7.16%12.19%
Upgrade
Return on Capital Employed (ROCE)
6.50%6.50%12.70%-12.20%21.80%
Upgrade
Earnings Yield
8.14%6.82%5.76%-46.18%18.09%21.90%
Upgrade
FCF Yield
21.36%17.90%97.75%3.19%4.93%41.87%
Upgrade
Dividend Yield
14.03%---2.16%3.89%
Upgrade
Payout Ratio
86.17%86.17%--25.22%17.58%
Upgrade
Buyback Yield / Dilution
-1.35%-0.04%----
Upgrade
Total Shareholder Return
12.69%-0.04%--2.16%3.89%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.